Two Sigma Securities, LLC Organon & Co. Call Options Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$13.78 - $18.8 $119,886 - $163,560
-8,700 Reduced 41.23%
12,400 $233,000
Q4 2023

Feb 14, 2024
BUY
$10.95 - $17.32 $31,754 - $50,228
2,900 Added 15.93%
21,100 $304,000
Q3 2023

Nov 14, 2023
BUY
$16.59 - $23.77 $39,816 - $57,048
2,400 Added 15.19%
18,200 $315,000
Q2 2023

Aug 14, 2023
BUY
$19.27 - $24.63 $304,466 - $389,154
15,800 New
15,800 $328,000
Q3 2022

Nov 14, 2022
BUY
$23.4 - $34.25 $358,020 - $524,025
15,300 New
15,300 $358,000

Others Institutions Holding OGN

# of Institutions
787
Shares Held
190M
Call Options Held
2.46M
Put Options Held
2.27M
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.17B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email